It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Thank you for your interest in the lupus nephritis clinical trial (NCT04181762).
Please fill out the form below to allow us to connect you to the right clinical trial site.


Which US state are you looking for a site in? *
Which Alabama site would you like to be referred to?
Which California site would you like to be referred to? *
Which Florida site would you like to be referred to? *
Which Georgia site would you like to be referred to?
Which Massachusetts site would you like to be referred to?
Which Michigan site would you like to be referred to?
Which Texas site would you like to be referred to?
Gender *
Best Time(s) to Contact *
Permission to leave voicemail including medical information? *
Have you been referred by a physician? *

* Required Field

Authorization to Use and Disclose Health Information

By signing this Authorization to Use and Disclose Health Information (the “Authorization”), I hereby authorize my health care providers, including any clinical trial sites I visit as part of considering clinical trial participation, and their vendors (“Providers”) to disclose information to Novartis Pharmaceuticals Corporation, its affiliates, business partners, and agents (“Novartis”) relating to my medical condition, treatment, clinical trial screening, and demographic information (“Health Information”) for the purposes described below:

- Coordinating and evaluating Novartis’ clinical trial recruitment process;
- Conduct quality assurance, surveys, and other internal business activities;
- Or as otherwise required by law.

I give permission to Novartis to disclose my Health Information to my Providers, insurer(s), caregivers, and other third-party contractors or service providers for the purposes described above. I also give permission to Novartis to combine or aggregate any Health Information collected from me with information Novartis may collect about me from other sources for the purposes described above. 

I understand that this Authorization is voluntary. My decision whether to sign this form will not affect my medical care or my eligibility for healthcare benefits. I understand that my Providers may receive remuneration (payment) from Novartis in exchange for disclosing my Health Information to Novartis.

I understand that I am entitled to receive a copy of this Authorization. I understand that I may revoke (withdraw) this Authorization at any time and for any reason in writing by contacting Clinical Trial Media (CTM) by emailing [email protected]. Revoking this Authorization will prevent Novartis from further using or disclosing my Health Information for the purposes set forth in this Authorization, but it will not affect uses and disclosures of my Health Information that were already made in reliance on this Authorization, and it will not affect recipients’ ability to use and disclose any of my Health Information that they have already received. 

I understand that once my Health Information has been disclosed, my Health Information may be subject to further disclosure by recipients and may no longer be protected by federal health information privacy laws. This Authorization shall remain in effect for one (1) year from the date of my signature, or earlier if required by state law, unless I cancel it sooner.  

I understand that the information I provide in this Authorization, [[including my telephone number, address, and e-mail address]] may be used to contact me for all purposes described in this Authorization. I confirm that I am the subscriber for the telephone number provided and the authorized user for the e-mail address provided, and I agree to promptly notify Novartis if my telephone number, address, or e-mail address change in the future. I understand that my wireless service provider’s message and data rates may apply.